New and Emerging Therapies for Metastatic Melanoma
Ryan J. Sullivan, MD, medical oncologist, Massachusetts General Hospital, gives an overview of new and emerging therapies for the treatment of metastatic melanoma.
Ryan J. Sullivan, MD, medical oncologist, Massachusetts General Hospital, gives an overview of new and emerging therapies for the treatment of metastatic melanoma.
Read more about the treatment of metastatic melanoma > >
Articles in this issue
Sequencing Strategies in Treating Patients With Melanoma
Research Into Newer Agents Under Way for NRAS Melanoma
New Crop of Combination Strategies Growing for Melanoma
An Overview of Immune Checkpoint Blockade
Approaches to Sequencing in Melanoma: Three Melanoma Specialists Weigh In
In Practice: Combination Therapies in Metastatic Melanoma
New and Emerging Therapies for Metastatic Melanoma
Mutation Tests in Melanoma Crucial for Treatment
What’s Next With Next-Generation BRAF Inhibitors?
Recent Videos
Anti–LAG-3/Anti–PD-1 Combo Demonstrates Sustained Efficacy in Melanoma
The Promise of OBX-115, a Novel TIL Therapy, in Melanoma
Amaria Highlights Phase 1 Trial of OBX-115 in Melanoma
Integrating Rheumatology Into Cancer Immunotherapy Care
Considering the Changing Treatment Landscape for Patients With Melanoma
The Real-World Challenges of Cell and Gene Therapy in Oncology
Oncologists Experience Improved Survival in Patients With Melanoma
Melanoma Treatment Advances: Fianlimab and Cemiplimab Show Promise
Understanding JZP898: A Breakthrough mRNA Therapy for Solid Tumors
Managing Immunotherapy Toxicities: Key Insights for Smaller and Resource-Limited Settings
Related Content
